The Risk of Cancer Associated with Anti-Diabetic Agents

被引：0
|
作者：
Zhang, Hui-Talia [1 ,2 ]
Hammad, Tarek A. [2 ]
Christiani, David [1 ]
Giovannuci, Edward [1 ]
机构：
[1] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[2] US FDA, Off Surveillance & Epidemiol, Silver Spring, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2009年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [21] Distinct effects of anti-diabetic medications on liver cancer risk and patient survival
    Chen, Pan-Hong
    Lu, Guo-Dong
    Zhu, Guang-Zhi
    Li, Li
    Chen, Yao
    Dai, Hui-Qi
    Su, Wen-Jing
    Wu, Yong
    Zhou, Jing
    JOURNAL OF BUON, 2020, 25 (05): : 2147 - 2153
  • [22] The Influence of Anti-Diabetic Drugs on Prostate Cancer
    Knura, Milosz
    Garczorz, Wojciech
    Borek, Adam
    Drzymala, Franciszek
    Rachwal, Krystian
    George, Kurian
    Francuz, Tomasz
    CANCERS, 2021, 13 (08)
  • [23] Metformin: An anti-diabetic drug to fight cancer
    Daugan, Marie
    Wojcicki, Amelie Dufay
    d'Hayer, Benoit
    Boudy, Vincent
    PHARMACOLOGICAL RESEARCH, 2016, 113 : 675 - 685
  • [24] Authors' response: metformin and risk of hepatocellular carcinoma-a study focused on anti-diabetic agents
    Wu, Chun-Ying
    Chen, Hsiao-Ping
    GUT, 2013, 62 (06) : 952 - 952
  • [25] Anti-diabetic potential of peptides: Future prospects as therapeutic agents
    Marya
    Khan, Haroon
    Nabavi, Seyed Mohammad
    Habtemariam, Solomon
    LIFE SCIENCES, 2018, 193 : 153 - 158
  • [26] Small molecule glucokinase activators as novel anti-diabetic agents
    Leighton, B
    Atkinson, A
    Coghlan, MP
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2005, 33 : 371 - 374
  • [27] Acute and chronic animal models for the evaluation of anti-diabetic agents
    Suresh Kumar
    Rajeshwar Singh
    Neeru Vasudeva
    Sunil Sharma
    Cardiovascular Diabetology, 11
  • [28] New anti-diabetic agents: major advances with unanswered questions
    Sabouret, Pierre
    Bocchino, Pier Paolo
    Biondi-Zoccai, Giuseppe
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2020, 21 (04) : 489 - 492
  • [29] Design, modification of phyllanthone derivatives as anti-diabetic and cytotoxic agents
    Ngoc-Hong Nguyen
    Van-Giau Vo
    Hoang-Vinh-Truong Phan
    Thanh-The Ngo
    Sichaem, Jirapast
    Thi-Phuong Nguyen
    Huu-Hung Nguyen
    Duc-Dung Pham
    Tien-Cong Nguyen
    Van-Kieu Nguyen
    Thuc-Huy Duong
    NATURAL PRODUCT RESEARCH, 2022, 36 (01) : 371 - 378
  • [30] Inhibition of tumor necrosis factor-α with anti-diabetic agents
    Fukuzawa, M
    Satoh, J
    Qiang, X
    Miyaguchi, S
    Sakata, Y
    Nakazawa, T
    Ikehata, F
    Ohta, S
    Toyota, T
    DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 43 (03) : 147 - 154
12345